Corning Inc. introduces a line of microcarriers for large-scale vaccine and cell therapy manufacturing.
The microcarriers provide a premeasured, sterile, ready-to-use product for direct transfer into bioreactors. This single-step microcarrier solution allows researchers to minimize lab preparation time and enhance manufacturing results.
The microcarriers offer Corning’s Synthemax II and Enhanced Attachment surface treatment options to maximize cell yield and viability, and are compatible with closed systems solutions packaging in customizable batch sizes starting at 10 g.
